Search research articles
Contact Us
Filters
Showing results (91-100 of 140) with videos related to
Page
of 14
Sort By:
Virology Journal
|
September 30, 2020
Viruses of protozoan parasites and viral therapy: Is the time now right?
Paul Barrow, Jean Claude Dujardin, Nicolas Fasel, et al.
Scientific Reports
|
March 1, 2019
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents
Andrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 22, 2024
Molecular monitoring of viral infections in immunocompromised patients in a large university hospital in Italy: reflections after thirteen years of real-life activity
Lilia Cinti, Piergiorgio Roberto, Matteo Rossi, et al.
Oncotarget
|
March 19, 2016
MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors
Matteo Rossi, David Colecchia, Gennaro Ilardi, et al.
Scientific Reports
|
November 24, 2019
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents
Andrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini, et al.
Risk Management and Healthcare Policy
|
July 16, 2021
Risk Analysis in Healthcare Organizations: Methodological Framework and Critical Variables
Giacomo Pascarella, Matteo Rossi, Emma Montella, et al.
Science Advances
|
October 31, 2020
ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression
Matteo Rossi Sebastiano, Chiara Pozzato, Maria Saliakoura, et al.
Cell Cycle (Georgetown, Tex.)
|
August 6, 2005
p53 codon 72 alleles influence the response to anticancer drugs in cells from aged people by regulating the cell cycle inhibitor p21WAF1
Stefano Salvioli, Massimiliano Bonafé, Cristiana Barbi, et al.
Chemmedchem
|
April 10, 2014
Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693
Mattia Mori, Giulia Vignaroli, Ylenia Cau, et al.
American Journal of Physiology. Renal Physiology
|
August 14, 2009
Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes
Elena Gagliardini, Daniela Corna, Carla Zoja, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 140) with videos related to
Sort By:
Page
of 14
Virology Journal
|
September 30, 2020
Viruses of protozoan parasites and viral therapy: Is the time now right?
Paul Barrow, Jean Claude Dujardin, Nicolas Fasel, et al.
Scientific Reports
|
March 1, 2019
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents
Andrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 22, 2024
Molecular monitoring of viral infections in immunocompromised patients in a large university hospital in Italy: reflections after thirteen years of real-life activity
Lilia Cinti, Piergiorgio Roberto, Matteo Rossi, et al.
Oncotarget
|
March 19, 2016
MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors
Matteo Rossi, David Colecchia, Gennaro Ilardi, et al.
Scientific Reports
|
November 24, 2019
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents
Andrea Costamagna, Matteo Rossi Sebastiano, Dora Natalini, et al.
Risk Management and Healthcare Policy
|
July 16, 2021
Risk Analysis in Healthcare Organizations: Methodological Framework and Critical Variables
Giacomo Pascarella, Matteo Rossi, Emma Montella, et al.
Science Advances
|
October 31, 2020
ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression
Matteo Rossi Sebastiano, Chiara Pozzato, Maria Saliakoura, et al.
Cell Cycle (Georgetown, Tex.)
|
August 6, 2005
p53 codon 72 alleles influence the response to anticancer drugs in cells from aged people by regulating the cell cycle inhibitor p21WAF1
Stefano Salvioli, Massimiliano Bonafé, Cristiana Barbi, et al.
Chemmedchem
|
April 10, 2014
Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693
Mattia Mori, Giulia Vignaroli, Ylenia Cau, et al.
American Journal of Physiology. Renal Physiology
|
August 14, 2009
Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes
Elena Gagliardini, Daniela Corna, Carla Zoja, et al.
Page
of 14